Background: The Aachen-Keratoprosthesis was designed to serve as a permanen
t keratoprosthesis, modeling natural corneal physical properties as closely
as possible. Prior to permanent application in patients, keratoprostheses
are commonly tested in animal models to assess biochemical and biomechanica
l compatibility. However, immune and inflammatory responses acquired throug
h animal experimentation are difficult to extrapolate in order to develop a
predictable and generalized outcome in humans. Therefore, this preliminary
report includes results following a temporary implantation of the Aachen-K
eratoprosthesis in a patient during vitreoretinal surgery to assess the lon
g-term prospect of application as a permanent artificial cornea.
Patient and Methods: A 43 year old man presented with a ruptured right eye
resulting in an opaque cornea and retinal detachment A soft silicone rubber
keratoprosthesis, the Aachen-Keratoprosthesis, was temporarily implanted S
ubretinal membranes were removed and the total retinal detachment was reatt
ached. Liquid perfluorocarbon and silicone oil were used. The temporary ker
atoprosthesis was replaced by a 7 mm corneal graft after completion of surg
ery.
Results: The Aachen-Keratoprosthesis was securely positioned into the treph
ined hole. It allowed complete visualisation of vitreous, retina and thus c
ontrolled manipulations in the vitreous cavity up to the extreme periphery.
Leakage across the trephination-prosthesis interface was minimal.
Conclusion: We report the first temporary application of an innovative kera
toprosthesis. its flexibility and good optical qualifies allow visualisatio
n and control of intraoperative procedures. This temporary pilot study of t
he Aachen KPro encourages further investigation of the Aachen KPro as a per
manent replacement for a diseased cornea.